Drug Interaction Report

Guggul and Heparin Injection: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Heparin Injection

Lipo-Hepin® Liquaemin® Panheparin®
+

Guggul

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 16 documented Guggul interactions, 16 are rated moderate — including this one.
Onset
delayed
Evidence
theoretical
Severity
Moderate

What happens

Increased risk of bleeding

Interaction Deep Dive

Theoretically, guggul may add to the risk of bleeding in patients taking anticoagulants. Guggul has increased fibrinolytic activity and reduced hypercoagulability by reducing serum lipids in humans12. Guggul inhibited platelet aggregation in vitro 3. Caution is advised if guggul and oral anticoagulants are taken concomitantly.

Why it happens (mechanism)

Increased fibrinolytic activity, inhibition of platelet aggregation, and reduced hypercoagulability as a result of reduced serum lipids

Literature reports

2 reports — tap to read

a) In a controlled trial with 40 patients, fraction A of gum guggul (0.5 grams twice a day) was shown to increase serum fibrinolytic activity by 22% within 24 hours, and 40% after one month, in healthy individuals. In patients with coronary artery disease, activity increased by 29.8% after 30 days. These effects persisted while guggul was administered and tended to return to baseline upon discontinuation (duration not given). Other studies have reported that the prothrombin times returned to baseline 3 weeks after discontinuation of guggul 1.

b) In a controlled trial using crude guggul, coagulation time was increased in 9 patients, of whom 6 were obese, 2 had ischemic heart disease, and 1 had cerebral thrombosis. This effect was thought to be directly related to the lowering of the amount of lipids in the bloodstream, preventing hypercoagulability. Serum turbidity was also shown to be decreased to almost normal levels 2.

Common questions

Can I take Guggul and Heparin Injection together?

Increased risk of bleeding Always confirm with your pharmacist or prescriber before making any change.

How serious is the Guggul and Heparin Injection interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Guggul or Heparin Injection need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (3)

  1. Bordia A & Chuttani SK: Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease. Indian J Med Res 1979; 70(Dec):992-996.
  2. Tripathi SN, Shastri VVS, & Scharya GVS: Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis. J Res Indian 1968; 2:140-154.
  3. Mester L, Mester M, & Nityanand S: Inhibition of platelet aggregation by "guggulu" steroids. Planta Med 1979; 37(4):367-369. PubMed
Was this write-up helpful?

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.